Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study

OBJECTIVE: To determine the association of primary tumor resection in stage IV pancreatic neuroendocrine tumors (Pan-NET) and survival in a propensity-score matched study. BACKGROUND: Pan-NET are often diagnosed with stage IV disease. The oncologic benefit from primary tumor resection in this scenar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjaer, Josefine, Clancy, Thomas E., Thornell, Anders, Andersson, Niklas, Hellman, Per, Crona, Joakim, Welin, Staffan, Sulciner, Megan, Powell, Brittany, Brais, Lauren, Astone, Kristina, Baddoo, William, Doherty, Gerhard, Chan, Jennifer A., Norlén, Olov, Stålberg, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2022
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431300/
https://www.ncbi.nlm.nih.gov/pubmed/37600107
http://dx.doi.org/10.1097/AS9.0000000000000151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431300/
https://www.ncbi.nlm.nih.gov/pubmed/37600107
http://dx.doi.org/10.1097/AS9.0000000000000151

Ejemplares similares